To include your compound in the COVID-19 Resource Center, submit it here.

Sequenom, Trovagene deal

TrovaGene (formerly Xenomics Inc.) said a 2008 deal that gave Sequenom rights to TrovaGene's transrenal technology was terminated.

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE